back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2020-03-20 15:11 Tx date 2020-03-19 |
$HUGE
FSD Pharma Inc. |
Fairfull, Thomas Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Multiple Voting Shares Class A
11 - Acquisition or disposition carried out privately
|
$-132.24
-24 vol $5.51 each |
0 | |
| Filed 2019-11-04 13:23 Tx date 2019-10-16 |
$HUGE
FSD Pharma Inc. |
Fairfull, Thomas Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: 1808066 Ontario Inc. (Indirect Ownership)
|
Subordinate Voting Shares Class B
37 - Stock split or consolidation
|
-9,950,249 vol |
49,751 | |
| Filed 2019-10-21 13:33 Tx date 2019-10-16 |
$HUGE
FSD Pharma Inc. |
Fairfull, Thomas Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: 1808066 Ontario Inc. (Control or Direction)
|
Subordinate Voting Shares Class B
37 - Stock split or consolidation
|
-9,950,249 vol |
||
| Filed 2019-10-21 13:33 Tx date 2019-10-16 |
$HUGE
FSD Pharma Inc. |
Fairfull, Thomas Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: 1808066 Ontario Inc. (Control or Direction)
|
Subordinate Voting Shares Class B
37 - Stock split or consolidation
|
-9,950,249 vol |
49,751 | |
| Filed 2019-10-21 13:32 Tx date 2019-10-16 |
$HUGE
FSD Pharma Inc. |
Fairfull, Thomas Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Multiple Voting Shares Class A
37 - Stock split or consolidation
|
-4,976 vol |
24 | |
| Filed 2019-10-21 13:31 Tx date 2019-10-16 |
$HUGE
FSD Pharma Inc. |
Fairfull, Thomas Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
37 - Stock split or consolidation
|
-39,485,317 vol |
197,426 | |
| Filed 2019-10-21 13:31 Tx date 2019-10-16 |
$HUGE
FSD Pharma Inc. |
Fairfull, Thomas Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-9,950,249 vol |
49,751 | |
| Filed 2019-01-09 Tx date 2018-12-31 |
$
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Fairfull, Thomas Alexander
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2019-01-07 Tx date 2019-01-04 |
$HUGE
FSD Pharma Inc. |
Fairfull, Thomas Alexander
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-10,000,000 vol |
10,000,000 | |
| Filed 2019-01-07 Tx date 2019-01-04 |
$HUGE
FSD Pharma Inc. |
Fairfull, Thomas Alexander
4 - Director of Issuer
Holder: 1808066 Ontario Inc. (Indirect Ownership)
|
Subordinate Voting Shares Class B
51 - Exercise of options
|
$220,000
+10,000,000 vol $0.022 each |
10,000,000 | |
| Filed 2019-01-07 Tx date 2018-05-24 |
$HUGE
FSD Pharma Inc. |
Fairfull, Thomas Alexander
4 - Director of Issuer
Holder: 1808066 Ontario Inc. (Indirect Ownership)
|
Subordinate Voting Shares Class B
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-10-19 Tx date 2018-10-17 |
$HUGE
FSD Pharma Inc. |
Fairfull, Thomas Alexander
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
11 - Acquisition or disposition carried out privately
|
$-8,465,651.84
-13,227,581 vol $0.64 each |
39,682,743 | |
| Filed 2018-05-28 Tx date 2018-05-24 |
$
FSD Pharma Inc. |
Fairfull, Thomas Alexander
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
00 - Opening Balance-Initial SEDI Report
|
52,910,324 | ||
| Filed 2018-05-28 Tx date 2018-05-24 |
$
FSD Pharma Inc. |
Fairfull, Thomas Alexander
4 - Director of Issuer
Direct Ownership
|
Multiple Voting Shares Class A
00 - Opening Balance-Initial SEDI Report
|
5,000 | ||
| Filed 2018-05-28 Tx date 2018-05-24 |
$
FSD Pharma Inc. |
Fairfull, Thomas Alexander
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
20,000,000 |